Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 14 studies | 26% ± 6% | |
lung | 11 studies | 27% ± 10% | |
intestine | 7 studies | 21% ± 10% | |
brain | 6 studies | 32% ± 11% | |
kidney | 5 studies | 22% ± 4% | |
eye | 5 studies | 25% ± 11% | |
lymph node | 5 studies | 25% ± 3% | |
pancreas | 4 studies | 43% ± 14% | |
liver | 4 studies | 28% ± 17% | |
prostate | 3 studies | 25% ± 4% | |
breast | 3 studies | 23% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2748.86 | 1445 / 1445 | 100% | 25.88 | 183 / 183 |
ovary | 100% | 2984.51 | 180 / 180 | 100% | 47.63 | 430 / 430 |
prostate | 100% | 5696.11 | 245 / 245 | 100% | 81.83 | 502 / 502 |
brain | 100% | 3838.48 | 2641 / 2642 | 100% | 37.45 | 705 / 705 |
breast | 100% | 3117.36 | 459 / 459 | 100% | 62.87 | 1116 / 1118 |
lung | 100% | 2690.81 | 577 / 578 | 100% | 34.93 | 1154 / 1155 |
uterus | 100% | 3082.02 | 170 / 170 | 100% | 39.28 | 457 / 459 |
thymus | 100% | 2795.34 | 653 / 653 | 100% | 59.07 | 602 / 605 |
bladder | 100% | 3222.00 | 21 / 21 | 99% | 35.19 | 500 / 504 |
skin | 100% | 3173.58 | 1809 / 1809 | 99% | 32.29 | 468 / 472 |
kidney | 100% | 2500.20 | 89 / 89 | 98% | 26.83 | 887 / 901 |
stomach | 100% | 2154.42 | 359 / 359 | 98% | 25.68 | 281 / 286 |
intestine | 100% | 2942.97 | 966 / 966 | 98% | 27.28 | 516 / 527 |
pancreas | 99% | 1728.94 | 325 / 328 | 98% | 32.17 | 175 / 178 |
adrenal gland | 100% | 2398.45 | 258 / 258 | 97% | 32.12 | 222 / 230 |
liver | 100% | 1373.87 | 226 / 226 | 96% | 22.97 | 390 / 406 |
adipose | 100% | 2653.74 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3424.01 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 25.53 | 29 / 29 |
spleen | 100% | 2263.60 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 27.36 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 21.62 | 1 / 1 |
muscle | 100% | 2129.20 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 1511.30 | 843 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 18.21 | 74 / 80 |
peripheral blood | 89% | 1493.02 | 824 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1903706 | Biological process | regulation of hemopoiesis |
GO_0001558 | Biological process | regulation of cell growth |
GO_2000779 | Biological process | regulation of double-strand break repair |
GO_0006338 | Biological process | chromatin remodeling |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_2000278 | Biological process | regulation of DNA biosynthetic process |
GO_1905168 | Biological process | positive regulation of double-strand break repair via homologous recombination |
GO_0006275 | Biological process | regulation of DNA replication |
GO_0050793 | Biological process | regulation of developmental process |
GO_0051726 | Biological process | regulation of cell cycle |
GO_0005730 | Cellular component | nucleolus |
GO_0000786 | Cellular component | nucleosome |
GO_0000776 | Cellular component | kinetochore |
GO_0005654 | Cellular component | nucleoplasm |
GO_0035267 | Cellular component | NuA4 histone acetyltransferase complex |
GO_0070776 | Cellular component | MOZ/MORF histone acetyltransferase complex |
GO_0000123 | Cellular component | histone acetyltransferase complex |
GO_0005634 | Cellular component | nucleus |
GO_0043997 | Molecular function | histone H4K12 acetyltransferase activity |
GO_0036408 | Molecular function | histone H3K14 acetyltransferase activity |
GO_0043996 | Molecular function | histone H4K8 acetyltransferase activity |
GO_0043995 | Molecular function | histone H4K5 acetyltransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | MEAF6 |
Protein name | Chromatin modification-related protein MEAF6 (MYST/Esa1-associated factor 6) (Esa1-associated factor 6 homolog) (Protein EAF6 homolog) (hEAF6) (Sarcoma antigen NY-SAR-91) Chromatin modification-related protein MEAF6 |
Synonyms | hCG_25685 EAF6 CENP-28 C1orf149 |
Description | FUNCTION: Component of the NuA4 histone acetyltransferase complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histone H4 and H2A . This modification may both alter nucleosome - DNA interactions and promote interaction of the modified histones with other proteins which positively regulate transcription . Component of HBO1 complexes, which specifically mediate acetylation of histone H3 at 'Lys-14' (H3K14ac), and have reduced activity toward histone H4 . Component of the MOZ/MORF complex which has a histone H3 acetyltransferase activity . . FUNCTION: Component of the NuA4 histone acetyltransferase complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histone H4 and H2A. This modification may both alter nucleosome - DNA interactions and promote interaction of the modified histones with other proteins which positively regulate transcription. Component of HBO1 complexes, which specifically mediate acetylation of histone H3 at 'Lys-14' (H3K14ac), and have reduced activity toward histone H4. Component of the MOZ/MORF complex which has a histone H3 acetyltransferase activity. . |
Accessions | ENST00000448519.2 [Q9HAF1-2] B1AK63 ENST00000296214.10 [Q9HAF1-1] Q9HAF1 ENST00000373074.5 ENST00000373073.8 [Q9HAF1-4] ENST00000373075.6 [Q9HAF1-3] |